AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

66.51

-0.39

(-0.58%)

At close: 04:00PM EDT

66.07

-0.44

(-0.65%)

After hours:

07:12PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	66.90
Open	66.26
Bid	65.35 x 3100
Ask	67.60 x 900
Day's Range	65.86 - 67.07
52 Week Range	53.63 - 71.70
Volume	4,635,385
Avg. Volume	6,915,269

Market Cap	206.111B
Beta (5Y Monthly)	0.12
PE Ratio (TTM)	N/A
EPS (TTM)	-0.36
Earnings Date	N/A
Forward Dividend & Yield	1.44 (2.28%)
Ex-Dividend Date	Feb 24, 2022
1y Target Est	71.80

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AZN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Astrazeneca PLC
Analyst Report: AstraZeneca PLCA merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Rating
Fair Value
Economic Moat
14 days agoMorningstar